Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.

Stürup AE, Jensen HD, Dolmer S, Birk M, Albert N, Nielsen M, Hjorthøj C, Eplov L, Ebdrup BH, Mors O, Nordentoft M.

Trials. 2017 Sep 29;18(1):445. doi: 10.1186/s13063-017-2172-4.


Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M.

Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13.


Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.

Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ.

Neuropsychiatr Dis Treat. 2016 Jan 6;12:57-67. doi: 10.2147/NDT.S96392. eCollection 2016. Review.


The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Brissos S, Veguilla MR, Taylor D, Balanzá-Martinez V.

Ther Adv Psychopharmacol. 2014 Oct;4(5):198-219. doi: 10.1177/2045125314540297. Review.


Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.

Miller BJ, Bodenheimer C, Crittenden K.

Clin Psychopharmacol Neurosci. 2011 Aug;9(2):45-53. doi: 10.9758/cpn.2011.9.2.45. Epub 2011 Aug 31.


The nature of relapse in schizophrenia.

Emsley R, Chiliza B, Asmal L, Harvey BH.

BMC Psychiatry. 2013 Feb 8;13:50. doi: 10.1186/1471-244X-13-50. Review.


An open trial of a new acceptance-based behavioral treatment for major depression with psychotic features.

Gaudiano BA, Nowlan K, Brown LA, Epstein-Lubow G, Miller IW.

Behav Modif. 2013 May;37(3):324-55. doi: 10.1177/0145445512465173. Epub 2012 Dec 6.


The myth of schizophrenia as a progressive brain disease.

Zipursky RB, Reilly TJ, Murray RM.

Schizophr Bull. 2013 Nov;39(6):1363-72. doi: 10.1093/schbul/sbs135. Epub 2012 Nov 20. Review.


Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.

Rossi G, Frediani S, Rossi R, Rossi A.

BMC Psychiatry. 2012 Aug 21;12:122. doi: 10.1186/1471-244X-12-122. Review.


Quantifying clinical relevance in the treatment of schizophrenia.

Correll CU, Kishimoto T, Nielsen J, Kane JM.

Clin Ther. 2011 Dec;33(12):B16-39. doi: 10.1016/j.clinthera.2011.11.016. Review.


Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.

Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU.

Mol Psychiatry. 2013 Jan;18(1):53-66. doi: 10.1038/mp.2011.143. Epub 2011 Nov 29. Review.


The management of schizophrenia: focus on extended-release quetiapine fumarate.

Peuskens J.

Neuropsychiatr Dis Treat. 2011;7:549-64. doi: 10.2147/NDT.S3380. Epub 2011 Sep 21.


Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.

Chen EY, Hui CL, Lam MM, Chiu CP, Law CW, Chung DW, Tso S, Pang EP, Chan KT, Wong YC, Mo FY, Chan KP, Yao TJ, Hung SF, Honer WG.

BMJ. 2010 Aug 19;341:c4024. doi: 10.1136/bmj.c4024.


The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W; Schizophrenia Patient Outcomes Research Team (PORT).

Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2. Review.


Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

Alvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF.

Schizophr Bull. 2011 May;37(3):619-30. doi: 10.1093/schbul/sbp129. Epub 2009 Nov 9. Review.


Clinical recovery in first-episode psychosis.

Wunderink L, Sytema S, Nienhuis FJ, Wiersma D.

Schizophr Bull. 2009 Mar;35(2):362-9. doi: 10.1093/schbul/sbn143. Epub 2008 Nov 5.


Psychopathology and treatment responsiveness of patients with first-episode schizophrenia.

Cesková E, Prikryl R, Kaspárek T, Ondrusová M.

Neuropsychiatr Dis Treat. 2005 Jun;1(2):179-85.


The recognition and optimal management of early psychosis: an evidence-based reform.

McGorry PD.

World Psychiatry. 2002 Jun;1(2):76-83. No abstract available.


Rationale and parameters for medication-free research in psychosis.

McGlashan TH.

Schizophr Bull. 2006 Apr;32(2):300-2. Epub 2006 Feb 3. No abstract available.

Supplemental Content

Support Center